Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

32

Revenue 2017

Truvada

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Truvada was produced by Gilead Sciences.

NHS England will make PrEP for HIV available in April

NHS England will make PrEP for HIV available in April

The PrEP Impact Trial is using Mylan's generic version of Gilead Sciences’ antiretroviral therapy Truvada (emtricitabine/tenofovir disoproxil) but is due to come to an end in October.

Gilead builds case for Descovy PrEP after FDA approval

Gilead builds case for Descovy PrEP after FDA approval Gilead wants to move quickly to transition people taking  Truvada for PrEP over to the new drug before Truvada generics start to reach the market next year. ... The prevalence of bone weakening (osteopenia) in the spine was also reduced from 0.6% in the

Gilead claims FDA okay for Descovy as second PrEP option

Gilead claims FDA okay for Descovy as second PrEP option In a statement, the FDA said that Descovy’s efficacy in preventing HIV transmission was similar to  Truvada(emtricitabine/tenofovir disoproxil fumarate), which became the first drug approved in the US ... The company will have to convince payers that

Redefining communications excellence

Redefining communications excellence In 2016, Gilead broke its self-enforced moratorium on the marketing of Truvada for PrEP, its drug for preventing HIV. ... A survey run in 2014 and 2015 found two-thirds of primary care physicians had never discussed Truvada for PrEP with their patients.

Janssen’s single tablet Symtuza gains NHS England funding 

Janssen’s single tablet Symtuza gains NHS England funding  A recent court case also saw Gilead's patent on Truvada overturned in the UK - which HIV campaigners hope will see greater use of the drug to prevent HIV infections.

1 2 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics